GIM
LMAT icon

Glenmede Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Glenmede Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$717K Sell
8,199
-736
-8% -$65.7K ﹤0.01% 804
2025
Q2 		$742K Buy
+8,935
New +$747K ﹤0.01% 800

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Investment Management's LMAT Position: Q3 2025 in Review

Glenmede Investment Management reduced its LeMaitre Vascular (LMAT) stake by 8.2% in Q3 2025, selling an estimated $65.7K and leaving 8,199 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #804.

Glenmede Investment Management first reported a position in LMAT in Q2 2025 and has held it in 2 quarters since. The position peaked at $742K in Q2 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Glenmede Investment Management held 8,199 shares of LeMaitre Vascular worth $717K as of Q3 2025.
  • Glenmede Investment Management sold 736 LeMaitre Vascular shares in Q3 2025, an estimated $65.7K.
  • LeMaitre Vascular made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #804 holding.
  • Glenmede Investment Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's LeMaitre Vascular position peaked at $742K in Q2 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.